INTRODUCTION: The incidence of chronic lung disease (CLD) varies among groups defined by their early pattern of respiratory disease. METHODS: The study examined data collected prospectively on 1204 of the 1506 infants born in 2002-2004 at 23-27 weeks gestation who survived to 36 weeks post-menstrual age. Based on their initial respiratory presentation and need for supplemental oxygen during the first 2 weeks, infants were classified as having early and persistent pulmonary dysfunction (EPPD), early recovery of pulmonary function followed by deterioration (PD) or consistently good pulmonary function characterised by low FiO(2) (Low FiO(2)). RESULTS: CLD was diagnosed in 69% of infants with EPPD, 52% with PD, and 17% in the Low FiO(2) group. Birth weight z score <-1 conveyed information about CLD risk in all three groups and was the major risk factor for infants in the Low FiO(2) group (OR 27; 95% CI 7 to 95). Mechanical ventilation at 7 days was associated with increased risk in the PD (OR 4.2, 95% CI 2.5 to 6.9) and EPPD groups (OR 2.7, 95% CI 1.5 to 4.7), but not the Low FiO(2) group (OR 1.5, 95% CI 0.5 to 3.9). CONCLUSION: The likelihood of a very preterm infant developing CLD and the profile of risk factors linked with CLD are related to the infant's pattern of respiratory disease during the first 2 postnatal weeks. Among infants with little exposure to oxygen during this period, fetal growth restriction, not mechanical ventilation, is the factor with the strongest association with CLD.
INTRODUCTION: The incidence of chronic lung disease (CLD) varies among groups defined by their early pattern of respiratory disease. METHODS: The study examined data collected prospectively on 1204 of the 1506 infants born in 2002-2004 at 23-27 weeks gestation who survived to 36 weeks post-menstrual age. Based on their initial respiratory presentation and need for supplemental oxygen during the first 2 weeks, infants were classified as having early and persistent pulmonary dysfunction (EPPD), early recovery of pulmonary function followed by deterioration (PD) or consistently good pulmonary function characterised by low FiO(2) (Low FiO(2)). RESULTS: CLD was diagnosed in 69% of infants with EPPD, 52% with PD, and 17% in the Low FiO(2) group. Birth weight z score <-1 conveyed information about CLD risk in all three groups and was the major risk factor for infants in the Low FiO(2) group (OR 27; 95% CI 7 to 95). Mechanical ventilation at 7 days was associated with increased risk in the PD (OR 4.2, 95% CI 2.5 to 6.9) and EPPD groups (OR 2.7, 95% CI 1.5 to 4.7), but not the Low FiO(2) group (OR 1.5, 95% CI 0.5 to 3.9). CONCLUSION: The likelihood of a very preterm infant developing CLD and the profile of risk factors linked with CLD are related to the infant's pattern of respiratory disease during the first 2 postnatal weeks. Among infants with little exposure to oxygen during this period, fetal growth restriction, not mechanical ventilation, is the factor with the strongest association with CLD.
Authors: Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins Journal: Pediatrics Date: 2005-03 Impact factor: 7.124
Authors: K J S Anand; R Whit Hall; Nirmala Desai; Barbara Shephard; Lena L Bergqvist; Thomas E Young; Elaine M Boyle; Ricardo Carbajal; Vinod K Bhutani; Mary Beth Moore; Shari S Kronsberg; Bruce A Barton Journal: Lancet Date: 2004-05-22 Impact factor: 79.321
Authors: Lisa A Joss-Moore; Yan Wang; Elizabeth M Ogata; Anthony J Sainz; Xing Yu; Christopher W Callaway; Robert A McKnight; Kurt H Albertine; Robert H Lane Journal: Birth Defects Res A Clin Mol Teratol Date: 2011-03-21
Authors: Robert M Joseph; Steven J Korzeniewski; Elizabeth N Allred; T Michael O'Shea; Tim Heeren; Jean A Frazier; Janice Ware; Deborah Hirtz; Alan Leviton; Karl Kuban Journal: Am J Obstet Gynecol Date: 2016-11-12 Impact factor: 8.661
Authors: Matthew Laughon; Carl Bose; Elizabeth N Allred; T Michael O'shea; Richard A Ehrenkranz; Linda J VAN Marter; Alan Leviton Journal: Pediatr Res Date: 2011-09 Impact factor: 3.756
Authors: Carl L Bose; Matthew M Laughon; Elizabeth N Allred; T Michael O'Shea; Linda J Van Marter; Richard A Ehrenkranz; Raina N Fichorova; Alan Leviton Journal: Cytokine Date: 2012-11-11 Impact factor: 3.861
Authors: Roberta L Keller; Rui Feng; Sara B DeMauro; Thomas Ferkol; William Hardie; Elizabeth E Rogers; Timothy P Stevens; Judith A Voynow; Scarlett L Bellamy; Pamela A Shaw; Paul E Moore Journal: J Pediatr Date: 2017-05-17 Impact factor: 4.406
Authors: Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe Journal: Nat Rev Dis Primers Date: 2019-11-14 Impact factor: 52.329
Authors: Jennifer J P Collins; Elke Kuypers; Ilias Nitsos; J Jane Pillow; Graeme R Polglase; Matthew W Kemp; John P Newnham; Jack P Cleutjens; Suzanna G M Frints; Suhas G Kallapur; Alan H Jobe; Boris W Kramer Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-09-07 Impact factor: 5.464
Authors: Shawn K Ahlfeld; Yong Gao; Jian Wang; Emrin Horgusluoglu; Esther Bolanis; D Wade Clapp; Simon J Conway Journal: Birth Defects Res A Clin Mol Teratol Date: 2013-05-30